The Online Investor
CRY Buyback image

CryoLife, Inc. Buyback

OLI recorded this information on 2/14/2013

Company: CryoLife, Inc.
Buyback: CRY buyback
$Amount Authorized: $15,000,000
Buyback Details: CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that its Board of Directors authorized the Company's purchase of $15 million of its common stock through October 31, 2014. Under this program, the purchase of shares can be made from time to time in the open market or through privately negotiated transactions on such terms as management deems appropriate, and will be dependent upon various factors, including price, regulatory requirements and other market conditions. The Company may enter into agreements from time to time that provide for common stock repurchases during Company announced "blackout periods" of such securities in compliance with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934. Pursuant to its credit facility the Company is entitled to repurchase up to approximately $10.2 million of its common stock without obtaining lender's consent.

Artivion is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. Co. has the following product families: aortic stents and stent grafts, surgical sealants, On-X® mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stents and stent grafts include JOTEC® stent grafts and surgical products, the Ascyrus Medical Dissection Stent hybrid prosthesis, and the NEXUS® endovascular stent graft system. Surgical sealants include BioGlue® Surgical Adhesive products.
Open the CRY Page at The Online Investor »

Company Name: 
Artivion Inc
Stock buyback: 
CRY buyback
Website: 
www.Artivion.com
Sector: 
Medical Instruments & Supplies
 

Open the CRY Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree CRY Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.33 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)

Analysts' Target Price:
CRY Stock Forecast

Based on Zacks ABR data;
powered by Xignite

CRY Buyback Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.